Hypothetical modeling about the cost effectiveness of kidney transplantation for end-stage renal disease: Untested assumptions, unaccounted variables and unknown consequences

Health Policy ◽  
2008 ◽  
Vol 88 (2-3) ◽  
pp. 392-396 ◽  
Author(s):  
Joseph L. Verheijde ◽  
Mohamed Y. Rady ◽  
Joan L. McGregor
Keyword(s):  
Kidney Transplantation ◽  
Cost Effectiveness ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Cost

Economic Evaluation of Kidney Transplantation versus Hemodialysis in Patients with End-Stage Renal Disease in Hungary

2001 ◽  
Vol 11 (3) ◽  
pp. 188-193 ◽  
Author(s):  
Zoltán Kaló ◽  
Jeno Járay ◽  
Júlia Nagy
Keyword(s):  
Kidney Transplantation ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Cost Effective ◽  
Effective Option ◽  
Hungarian Population ◽  
Cadaveric Kidney ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Cost

Background— Kidney transplantation is generally acknowledged as the more clinically effective and more cost-effective option in managing patients with end-stage renal disease, compared with dialysis. This study looked for confirmatory evidence in a Hungarian population. Methods— Patients (n = 242) with end-stage renal disease who received cadaveric kidney transplantation during 1994 were followed up for 3 years. They were compared with patients (n = 840) receiving hemodialysis who were on a waiting list for transplantation. Data were collected retrospectively. Treatments were compared for clinical efficacy and for cost-effectiveness. Results— At month 36, the standard mortality hazard function was 3.5 times higher in the group receiving hemodialysis ( P<.0001) than in the transplant recipients. Average treatment costs per patient over the 3 years were also significantly higher ( P<.0001) in the hemodialysis group than in the group that received transplants. The cost of 1 year gained by transplantation was significantly less ( P<.0001) than the cost associated with hemodialysis. Conclusions— Compared with hemodialysis, kidney transplantation provides greater survival benefits to patients with end-stage renal disease, at less cost.

scholarly journals The Cost-effectiveness of Managing Non-healing Foot Wounds in Patients with Critical Limb Ischemia and End-Stage Renal Disease

2013 ◽  
Vol 58 (3) ◽  
pp. 850-851
Author(s):  
Neal R. Barshes ◽  
Panos Kougias ◽  
C. Keith Ozaki ◽  
Philip P. Goodney ◽  
Michael Belkin
Keyword(s):  
Cost Effectiveness ◽  
Renal Disease ◽  
Critical Limb Ischemia ◽  
End Stage Renal Disease ◽  
Limb Ischemia ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Cost

scholarly journals Modelling the Cost-Effectiveness of Delaying End-Stage Renal Disease

Nephron ◽  
2016 ◽  
Vol 133 (2) ◽  
pp. 89-97 ◽  
Author(s):  
Eline F. de Vries ◽  
Ton J. Rabelink ◽  
Wilbert B. van den Hout
Keyword(s):  
Cost Effectiveness ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Cost

scholarly journals Significant Decrease in Plasma N-Acetyl-seryl-aspartyl-lysyl-proline Level in Patients with End Stage Renal Disease after Kidney Transplantation

2014 ◽  
Vol 37 (6) ◽  
pp. 1075-1079 ◽  
Author(s):  
Yosuke Suzuki ◽  
Fumihiko Katagiri ◽  
Fuminori Sato ◽  
Kanako Fujioka ◽  
Yukie Sato ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Proline Level ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document